114 related articles for article (PubMed ID: 6471583)
1. [Effects of water purification on renal osteodystrophy in the patients with regular hemodialysis therapy].
Masuyama J; Tachibana Y
Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):407-16. PubMed ID: 6471583
[No Abstract] [Full Text] [Related]
2. [Serum calcium, phosphorus and alkaline phosphatase as indicators in the therapy of renal osteodystrophy].
Labos I; Kovacević M
Med Arh; 1988; 42(4):181-5. PubMed ID: 3270761
[No Abstract] [Full Text] [Related]
3. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
[TBL] [Abstract][Full Text] [Related]
4. Renal osteodystrophy in course of periodic dialysis for chronic uremia.
Kim D; Bell NH; Bundesen W; Putong P; Simon NM; Walker C; Del Greco F
Trans Am Soc Artif Intern Organs; 1968; 14():367-71. PubMed ID: 5701557
[No Abstract] [Full Text] [Related]
5. Fluoride and dialysis osteodystrophy: results of a double-blind study.
Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA
Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422
[No Abstract] [Full Text] [Related]
6. The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings.
Duarte ME; Peixoto AL; Pacheco AS; Peixoto AV; Rodriguez RD; Lugon JR; Cruz EA
Sao Paulo Med J; 1998; 116(5):1790-7. PubMed ID: 10030103
[TBL] [Abstract][Full Text] [Related]
7. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
[No Abstract] [Full Text] [Related]
8. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
[No Abstract] [Full Text] [Related]
9. [Subtotal parathyroidectomy in the treatment of renal osteodystrophy in 8 patients under chronic hemodialysis].
Lillo M
Rev Med Chil; 1984 Jun; 112(6):564-9. PubMed ID: 6515169
[No Abstract] [Full Text] [Related]
10. Osteodystrophy of dialysed patients treated with vitamin D.
Verberckmoes R; Bouillon R; Krempien B
Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
[No Abstract] [Full Text] [Related]
11. Renal osteodystrophy in children: the effect of hemodialysis and renal homotransplantation.
Fine RN; Isaacson AS; Payne V; Grushkin CM
J Pediatr; 1972 Feb; 80(2):243-9. PubMed ID: 4550451
[No Abstract] [Full Text] [Related]
12. Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.
Gokal R; Ramos JM; Ellis HA; Parkinson I; Sweetman V; Dewar J; Ward MK; Kerr DN
Kidney Int; 1983 Jan; 23(1):15-21. PubMed ID: 6834691
[No Abstract] [Full Text] [Related]
13. Preparation of water by reverse osmosis for hemodialysis and coil storage and reuse.
Hurwich BJ
Isr J Med Sci; 1972 May; 81(5):602-5. PubMed ID: 5065043
[No Abstract] [Full Text] [Related]
14. Aluminium-related osteodystrophy and desferrioxamine treatment: role of phosphorus.
Jorgetti V; Soeiro NM; Mendes V; Pereira RC; Crivellari ME; Coutris G; Borelli A; Leite MO; Nussenzweig I; Marcondes M
Nephrol Dial Transplant; 1994; 9(6):668-74. PubMed ID: 7970094
[TBL] [Abstract][Full Text] [Related]
15. Long-term experience of alfacalcidol in renal osteodystrophy.
Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
[TBL] [Abstract][Full Text] [Related]
16. Marked improvement in parameters of renal osteodystrophy with the use of intraperitoneal calcitriol.
Arora N; Sandroni S; Moles K
Adv Perit Dial; 1992; 8():62-4. PubMed ID: 1361854
[TBL] [Abstract][Full Text] [Related]
17. [Physiopathology of renal osteodystrophy. II. During chronic hemodialysis and after kidney transplantation].
Fournier A; Bordier P; Weil B; Safar M; Idatte JM
Presse Med (1893); 1971 Nov; 79(50):2291-6. PubMed ID: 4943105
[No Abstract] [Full Text] [Related]
18. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
Goulding A; McChesney R; Irvine RO; Dixon SR
N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274
[No Abstract] [Full Text] [Related]
19. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L
J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182
[No Abstract] [Full Text] [Related]
20. [Evaluation of osteodystrophy parameters in a pre-dialysis unit].
Barril G; Sanz P; Bardón E; Andrino T; Cigarrán S; Díaz A; Selgas R
Nefrologia; 2003; 23 Suppl 2():43-6. PubMed ID: 12778853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
